QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, March 3, 2004, 24(9):2270-2276; doi:10.1523/JNEUROSCI.1658-03.2004

This Article Full Text Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (68) Citing Articles via Google Scholar Google Scholar Articles by Spires, T. L. Articles by Hannan, A. J. Search for Related Content PubMed PubMed Citation Articles by Spires, T. L. Articles by Hannan, A. J.

 Previous Article  |  Next Article 

Development/Plasticity/Repair
Environmental Enrichment Rescues Protein Deficits in a Mouse Model of Huntington's Disease, Indicating a Possible Disease Mechanism

Tara L. Spires, Helen E. Grote, Neelash K. Varshney, Patricia M. Cordery, Anton van Dellen, Colin Blakemore, and Anthony J. Hannan

University Laboratory of Physiology, University of Oxford, Oxford OX1 3PT, United Kingdom

Huntington's disease (HD) is a devastating neurodegenerative disorder caused by a CAG repeat expansion encoding an extended polyglutamine tract in the huntingtin protein. Transgenic mice expressing a human huntingtin transgene containing an expanded CAG repeat (R6/1 model) develop a neurodegenerative disorder closely resembling human HD. Previous work demonstrated that environmental enrichment delays the onset of motor symptoms in this mouse model. We confirmed that at 5 months of age, enrichment ameliorates motor symptoms (assessed using the rotarod test) and prevents loss of body weight induced by the HD transgene. We further examined molecular consequences of enrichment by determining changes in protein levels in the neostriatum, hippocampus, and anterior cortex using quantitative Western blot analysis. Non-enriched HD mice have severe reductions in BDNF in the hippocampus and striatum at 5 months, which are entirely rescued by enrichment. BDNF levels are unaltered by HD in the anterior cortex, suggesting that enrichment might prevent HD-induced impairment of anterograde transport of this neurotrophin to the striatum. NGF is unaffected by HD. Non-enriched HD mice also exhibit deficits in dopamine and cAMP-regulated phosphoprotein (32 kDa) in striatum and anterior cortex. Environmental enrichment rescues the cortical but not the striatal deficit at 5 months. These results suggest that environmental enrichment benefits animals at early stages of the disease by rescuing protein deficits, possibly through rescuing transcription or protein transport problems.

Key words: Huntington's disease; environmental enrichment; BDNF; DARPP-32; transgenic mouse model; R6/1; NGF

---

Received Aug 20, 2003; revised January 12, 2004; accepted January 20, 2004.

This article has been cited by other articles:

				T. Y.C. Pang, X. Du, M. S. Zajac, M. L. Howard, and A. J. Hannan Altered serotonin receptor expression is associated with depression-related behavior in the R6/1 transgenic mouse model of Huntington's disease Hum. Mol. Genet., February 15, 2009; 18(4): 753 - 766. [Abstract] [Full Text] [PDF]

				H. Seo, W. Kim, and O. Isacson Compensatory changes in the ubiquitin-proteasome system, brain-derived neurotrophic factor and mitochondrial complex II/III in YAC72 and R6/2 transgenic mice partially model Huntington's disease patients Hum. Mol. Genet., October 15, 2008; 17(20): 3144 - 3153. [Abstract] [Full Text] [PDF]

				K. Littin, A. Acevedo, W. Browne, J. Edgar, M. Mendl, D. Owen, C. Sherwin, H. Wurbel, and C. Nicol Towards humane end points: behavioural changes precede clinical signs of disease in a Huntington's disease model Proc R Soc B, August 22, 2008; 275(1645): 1865 - 1874. [Abstract] [Full Text] [PDF]

				P. Zinzi, D. Salmaso, R. De Grandis, G. Graziani, S. Maceroni, A. Bentivoglio, P. Zappata, M. Frontali, and G. Jacopini Effects of an intensive rehabilitation programme on patients with Huntington's disease: a pilot study Clinical Rehabilitation, July 1, 2007; 21(7): 603 - 613. [Abstract] [PDF]

				G. Lynch, E. A. Kramar, C. S. Rex, Y. Jia, D. Chappas, C. M. Gall, and D. A. Simmons Brain-Derived Neurotrophic Factor Restores Synaptic Plasticity in a Knock-In Mouse Model of Huntington's Disease J. Neurosci., April 18, 2007; 27(16): 4424 - 4434. [Abstract] [Full Text] [PDF]

				F. L. Huang, K.-P. Huang, J. Wu, and C. Boucheron Environmental enrichment enhances neurogranin expression and hippocampal learning and memory but fails to rescue the impairments of neurogranin null mutant mice. J. Neurosci., June 7, 2006; 26(23): 6230 - 6237. [Abstract] [Full Text] [PDF]

				G. L. Dunbar, M. I. Sandstrom, J. Rossignol, and L. Lescaudron Neurotrophic Enhancers as Therapy for Behavioral Deficits in Rodent Models of Huntington's Disease: Use of Gangliosides, Substituted Pyrimidines, and Mesenchymal Stem Cells. Behav Cogn Neurosci Rev, June 1, 2006; 5(2): 63 - 79. [Abstract] [PDF]

				A. J. Milnerwood, D. M. Cummings, G. M. Dallerac, J. Y. Brown, S. C. Vatsavayai, M. C. Hirst, P. Rezaie, and K. P.S.J. Murphy Early development of aberrant synaptic plasticity in a mouse model of Huntington's disease Hum. Mol. Genet., May 15, 2006; 15(10): 1690 - 1703. [Abstract] [Full Text] [PDF]

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help